[Transitory agranulocytosis of toxic origin in a child (during treatment with oxyphenylbutazone and sulfamethoxazole-trimethoprim)].
D000380:Agranulocytosis / Q000139:chemically induced*; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000627:therapeutic use; D005334:Fever / Q000188:drug therapy; D006801:Humans; D008297:Male; D010113:Oxyphenbutazone / Q000009:adverse effects* / Q000627:therapeutic use; D012480:Salmonella Infections / Q000188:drug therapy*; D012640:Seizures / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000009:adverse effects* / Q000627:therapeutic use; D014295:Trimethoprim / Q000009:adverse effects* / Q000627:therapeutic use
D004917:Erythromycin; D014295:Trimethoprim; D010113:Oxyphenbutazone; D013420:Sulfamethoxazole
Agranulocytose transitoire d'origine toxique chez lenfant (au cours d'un traitement par oxyphényl-butazone et sulfaméthoxazole-triméthoprime)